DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Artificial Pancreas Device Systems Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts - 2014 to 2022" report to their offering.
The artificial pancreas device systems market was valued at USD 59.8 Mn in 2015, and is expected to reach USD 335.5 Mn by 2022, expanding at a CAGR of 21.7% from 2016 to 2022.
An artificial pancreas system comprises a continuous glucose monitor (CGM) and a continuous subcutaneous insulin infusion pump, both of which are available in the market today, and a controller linking the monitor and pump. It runs a highly sophisticated algorithm to determine the appropriate amount of insulin to deliver and the timing for that delivery, based on evaluation of real-time glucose readings. The market segmentation of artificial pancreas device systems market by type of devices comprises threshold suspend device system, control-to-range (CTR) system, and control-to-target (CTT) system. The geographical segmentation of global artificial pancreas device systems market comprises North America, Europe, Asia Pacific, Latin America and Middle East and Africa further segmented into key countries with highest potential in artificial pancreas device systems market.
Threshold suspended device system is expected to account for the largest market due to early bird benefits and swift market expansion and penetration characteristics possessed as Medtronic, Inc. is a multinational company with operations in more than 140 countries. However, in 2018 products in CTT systems are expected to boost the overall market growth of the artificial pancreas device and systems market because around five companies are expected to enter the market. North America is expected to be the largest and most potential regional market for artificial pancreas device systems due to high disposable income, rising prevalence of type 1 diabetes, high adoption rate of novel technologies and supportive reimbursement policies.
- Johnson & Johnson
- Medtronic, Inc.
- Pancreum LLC
Tandem Diabetes Care, Inc.
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Artificial Pancreas Device Systems: Market Dynamics and Outlook
Chapter 4 Global Artificial Pancreas Device Systems Market, by Device Type
Chapter 5 Global Artificial Pancreas Device System Market, By Geography
Chapter 6 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/qfrgrk/global_artificial